News

On January 13, 2022, Green Valley (Shanghai) Pharmaceuticals Co., Ltd. received the letter from the US Food and Drug Administration (FDA) on the Investigational New Drug (IND)…
Read More...

Abbisko Therapeutics Co., Ltd. announced that it has entered into a worldwide collaboration and exclusive licensing agreement (the "Agreement") with Eli Lilly and Company ("Lilly") for…
Read More...

Ono Pharmaceutical Co., Ltd. announced that it has signed an expanded drug discovery collaboration agreement with Neurimmune AG (Zurich, Switzerland; CEO, Roger M Nitsch; “Neurimmune”).…
Read More...

Vertex Pharmaceuticals Incorporated announced that the European Commission has granted approval for the label extension of KAFTRIO (ivacaftor/tezacaftor/elexacaftor) in a combination…
Read More...

BenevolentAI, a leading clinical-stage AI drug discovery company, has expanded its AI-driven drug discovery collaboration with AstraZeneca, doubling the number of disease areas being…
Read More...

GlaxoSmithKline plc and Vir Biotechnology, Inc. announced that the US Government will purchase an additional 600,000 doses of sotrovimab, an investigational monoclonal antibody for the…
Read More...

ABL Bio, Inc. announced an exclusive collaboration and worldwide license agreement with SANOFI to develop and commercialize ABL301, a pre-clinical stage bispecific antibody targeting…
Read More...

Neutron Therapeutics, a targeted radiation therapy company developing a comprehensive solution for Boron Neutron Capture Therapy (BNCT), and Cosylab, the world’s leading provider of…
Read More...

BigHat Biosciences, Inc., a biotechnology company with an artificial intelligence/machine learning-guided antibody discovery and development platform, announced the successful…
Read More...

Adamis Pharmaceuticals Corporation nnounced the submission of a Fast Track Application to the U.S. Food and Drug Administration (FDA) for Tempol for the treatment and prevention of…
Read More...

Novartis and Molecular Partners announced that Part A of the EMPATHY clinical trial1 that compared single intravenous doses of ensovibep, a DARPin antiviral therapeutic candidate vs.…
Read More...

Bayer AG and Mammoth Biosciences, Inc., which is harnessing the diversity of nature to power the next-generation CRISPR products, announced a strategic collaboration and option…
Read More...

Pfizer Inc. and Acuitas Therapeutics, a company focused on developing lipid nanoparticle (LNP) delivery systems to enable messenger RNA (mRNA)-based therapeutics, announced they have…
Read More...

Century Therapeutics and Bristol Myers Squibb announced today a research collaboration and license agreement (the “agreement”) to develop and commercialize up to four induced…
Read More...

Johnson & Johnson announced new results from the largest study to date on the durability of COVID-19 vaccines in the United States (U.S.), showing that a single shot of the Johnson…
Read More...

Amgen and Generate Biomedicines announced a research collaboration agreement to discover and create protein therapeutics for five clinical targets across several therapeutic areas and…
Read More...

TRexBio Inc., a discovery stage company decoding tissue immune biology to create revolutionary therapeutics, announced that it has entered into a multi-year research collaboration and…
Read More...

Pfizer Inc. and BioNTech SE announced a new research, development and commercialization collaboration to develop a potential first mRNA-based vaccine for the prevention of shingles…
Read More...

SRI International (SRI) announced the company has entered into a collaboration agreement with Janssen Pharmaceutica NV (Janssen), one of the Janssen Pharmaceutical Companies of Johnson…
Read More...

NRx Pharmaceuticals announced that it has submitted an application for Emergency Use Authorization (EUA) to the US Food and Drug Administration (FDA) for the use of ZYESAMI (aviptadil)…
Read More...